Neuroprotection in Huntington;s Disease

E-ISSN： 1875-628x|2|2|143-147

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.2, Iss.2, 2005-03, pp. : 143-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic strategies in Huntington’s disease

By Alberch Jordi Canals Josep M Pérez-Navarro Esther

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 449-465

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic targets for Huntington’s disease

By Hannan Anthony J

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite

A review of the treatment options for Huntington’s disease

By Bonelli Raphael M Hofmann Peter

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 767-776

Informa Healthcare

Access to resources Recommend Favorite

Emerging chemotherapeutic strategies for Huntington’s disease

By Ryu Hoon Ferrante Robert J

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 345-363

Informa Healthcare

Access to resources Recommend Favorite

Neural Transplantation in Patients with Huntingtons Disease

By Rosser A.E. Dunnett S.B.

CNS Drugs, Vol. 17, Iss. 12, 2003-01 ,pp. : 853-867

Adis International

Access to resources Recommend Favorite